Nephros (NEPH) Current Leases (2019 - 2020)
Nephros (NEPH) posted quarterly Current Leases of $332000.0 for Q4 2020, up 26.72% year-over-year from $262000.0 in Q1 2020, and up 1.84% quarter-over-quarter from $326000.0 in Q3 2020.
Nephros (NEPH) Current Leases (2019 - 2020) Analysis & Trends
Nephros' Current Leases history runs 2 years deep, the most recent figure standing at $332000.0 for Q4 2020.
- In Q4 2020, Current Leases rose 26.72% year-over-year to $332000.0; the TTM figure through Dec 2020 stood at $332000.0 (up 26.72% YoY), while the FY2020 annual figure was $332000.0, up 26.72% from the prior year.
- Current Leases for Q4 2020 stood at $332000.0, up from $326000.0 in the prior quarter.
- The five-year high for Current Leases was $332000.0 in Q4 2020, with the low at $191000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.60 Bn | 129.38 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.48 Bn | 51.62 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.74 Bn | 34.39 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.95 Bn | 32.48 Bn | 861.22 Mn | 29.14 Mn |
| 5 | Medline | 28.97 Bn | 26.29 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.05 Bn | 24.61 Bn | 329.20 Mn | 20.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | - |
| 10 | Nephros | 47.77 Mn | 43.07 Mn | 4.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 332,000.00 |
| Sep 30, 2020 | 326,000.00 |
| Jun 30, 2020 | 315,000.00 |
| Mar 31, 2020 | 312,000.00 |
| Dec 31, 2019 | 262,000.00 |
| Sep 30, 2019 | 251,000.00 |
| Jun 30, 2019 | 223,000.00 |
| Mar 31, 2019 | 191,000.00 |